Musclepharm Corp Stock Revenue
| MSLPDelisted Stock | USD 0 0.0002 15.38% |
Musclepharm Corp fundamentals help investors to digest information that contributes to Musclepharm Corp's financial success or failures. It also enables traders to predict the movement of Musclepharm Pink Sheet. The fundamental analysis module provides a way to measure Musclepharm Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Musclepharm Corp pink sheet.
Musclepharm |
Musclepharm Corp Company Revenue Analysis
Musclepharm Corp's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Musclepharm Corp Revenue | 50.04 M |
Most of Musclepharm Corp's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Musclepharm Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Musclepharm Corp reported 50.04 M of revenue. This is 99.66% lower than that of the Personal Products sector and 99.4% lower than that of the Consumer Staples industry. The revenue for all United States stocks is 99.47% higher than that of the company.
Musclepharm Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Musclepharm Corp's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Musclepharm Corp could also be used in its relative valuation, which is a method of valuing Musclepharm Corp by comparing valuation metrics of similar companies.Musclepharm Corp is currently under evaluation in revenue category among related companies.
Musclepharm Fundamentals
| Return On Asset | -0.66 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.23) % | |||
| Current Valuation | 22.12 M | |||
| Shares Outstanding | 34.35 M | |||
| Shares Owned By Insiders | 53.50 % | |||
| Shares Owned By Institutions | 15.05 % | |||
| Price To Sales | 0 X | |||
| Revenue | 50.04 M | |||
| Gross Profit | 5.37 M | |||
| EBITDA | (7.07 M) | |||
| Net Income | (12.87 M) | |||
| Cash And Equivalents | 534 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 22.64 M | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 0.25 X | |||
| Book Value Per Share | (1.14) X | |||
| Cash Flow From Operations | (8.04 M) | |||
| Earnings Per Share | (0.58) X | |||
| Price To Earnings To Growth | (0.10) X | |||
| Target Price | 1.65 | |||
| Number Of Employees | 21 | |||
| Beta | -0.0524 | |||
| Market Capitalization | 6.87 K | |||
| Total Asset | 11.21 M | |||
| Retained Earnings | (159.76 M) | |||
| Working Capital | (20.99 M) | |||
| Current Asset | 32.9 M | |||
| Current Liabilities | 53.88 M | |||
| Z Score | -16.8 | |||
| Net Asset | 11.21 M |
About Musclepharm Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Musclepharm Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Musclepharm Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Musclepharm Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Musclepharm Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Musclepharm Corp's short interest history, or implied volatility extrapolated from Musclepharm Corp options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Musclepharm Pink Sheet
If you are still planning to invest in Musclepharm Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Musclepharm Corp's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |